Systemic sclerosis & Raynaud's
Well-Being Therapy in systemic sclerosis outpatients: a randomized controlled trial
Authors' conclusion
The study provides preliminary evidence on the benefits of WBT as short-term approach for in- and out-patient SSc healthcare paths.
Study context
- Population
- Systemic sclerosis (SSc) outpatients
- Participants
- 32 outpatients
- Comparison
- Well-Being Therapy vs treatment as usual
- Well-Being Therapy (WBT)n = 16
- TAUn = 16reference
- Primary endpoint
- Well-being
Methodological details1:1 randomisation
- 1:1 randomisation
Primary result
As reported in the abstract
Well-being, WBT vs TAU
- WBT vs TAU: P ≤ 0.001
- WBT vs TAU: P = 0.006
- WBT vs TAU: P = 0.003
Secondary outcomes
| Outcome | P value |
|---|---|
| Subjective well-being, maintained · T3 (7 months) | P = 0.012 |
| Decrease in psychological distress, mental pain and sufferingWBT vs TAU · psychological distress | P = 0.010 |
| Decrease in psychological distress, mental pain and sufferingWBT vs TAU · mental pain | P = 0.010 |
| Decrease in psychological distress, mental pain and sufferingWBT vs TAU · suffering | P ≤ 0.001 |
| Suffering, maintained · T4 (10 months) | P ≤ 0.001 |
Satisfaction with WBT
- Participants reported high satisfaction with WBT
Original publication
Well-Being Therapy in systemic sclerosis outpatients: a randomized controlled trial. Rheumatology (Oxford). Published 17 February 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →